Adverse effects including persistent nausea, vomiting, abdominal pain, or suspected pancreatitis require immediate medical attention and Yellow Card reporting
These medications are expensive, demand is high, and federal healthcare programs, including TRICARE, are managing access rather than expanding it without limits
We have witnessed improved joint mobility in patients using GLP-1 therapy, offering a comprehensive approach to managing joint pain alongside other metabolic benefits
Gomes et al
In 2021, the sales of Lilly's long-acting GLP-1 receptor agonist product dulaglutide were US$6.472 billion, up 49% from the previous year
GLP-1 is a multitasking hormone with wide-ranging physiological effects, particularly in the context of nutrient intake and metabolic control